Literature DB >> 6253526

Deficiency of protein C inhibitor in combined factor V/VIII deficiency disease.

R A Marlar, J H Griffin.   

Abstract

Activated protein C is an anticoagulant plasma protease enzyme that inactivates Factors V and VIII in plasma. Normal plasma contains a protein that inhibits activated protein C and that is distinct from previously described plasma protease inhibitors. Protein C inhibitory activity is not detectable in plasmas from four unrelated patients with combined Factor V/VIII deficiency but is present in normal amounts in plasmas from patients with simple factor V deficiency or Factor VIII deficiency. It is suggested that the molecular basis for combined Factor V/VIII deficiency that exhibits simple autosomal recessive inheritance is a deficiency of protein C inhibitor.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6253526      PMCID: PMC371561          DOI: 10.1172/JCI109952

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  20 in total

1.  Human factor XII (Hageman factor).

Authors:  J H Griffin; C G Cochrane
Journal:  Methods Enzymol       Date:  1976       Impact factor: 1.600

2.  A new vitamin K-dependent protein. Purification from bovine plasma and preliminary characterization.

Authors:  J Stenflo
Journal:  J Biol Chem       Date:  1976-01-25       Impact factor: 5.157

3.  A new vitamin K-dependent protein. A phospholipid-binding zymogen of a serine esterase.

Authors:  C T Esmon; J Stenflo; J W Suttie
Journal:  J Biol Chem       Date:  1976-05-25       Impact factor: 5.157

4.  Relationship of "new" vitamin K-dependent Protein C and "old" autoprothrombin II-a.

Authors:  W H Seegers; E Novoa; R L Henry; H I Hassouna
Journal:  Thromb Res       Date:  1976-05       Impact factor: 3.944

5.  Combined deficiency of factor V and factor VIII: report of a family and genetic analysis.

Authors:  C T Sibinga; J D Gökemeyer; L P ten Kate; F Bos-van Zwol
Journal:  Br J Haematol       Date:  1972-10       Impact factor: 6.998

6.  Inhibitor of human blood coagulation elicited by thrombin.

Authors:  E Marciniak
Journal:  J Lab Clin Med       Date:  1972-06

7.  Combined factor-V and factor-VIII deficiency: report of four cases.

Authors:  U Seligsohn; B Ramot
Journal:  Br J Haematol       Date:  1969-05       Impact factor: 6.998

8.  The mechanism of activation of bovine prothrombin by an activator isolated from Echis carinatus venon and characterization of the new active intermediates.

Authors:  T Morita; S Iwanaga; T Suzuki
Journal:  J Biochem       Date:  1976-05       Impact factor: 3.387

9.  Proteolytic activation of protein C from bovine plasma.

Authors:  W Kisiel; L H Ericsson; E W Davie
Journal:  Biochemistry       Date:  1976-11-02       Impact factor: 3.162

10.  Immunologic differentiation of classic hemophilia (factor 8 deficiency) and von Willebrand's dissase, with observations on combined deficiencies of antihemophilic factor and proaccelerin (factor V) and on an acquired circulating anticoagulant against antihemophilic factor.

Authors:  T S Zimmerman; O D Ratnoff; A E Powell
Journal:  J Clin Invest       Date:  1971-01       Impact factor: 14.808

View more
  35 in total

1.  Linkage of combined factors V and VIII deficiency to chromosome 18q by homozygosity mapping.

Authors:  W C Nichols; U Seligsohn; A Zivelin; V H Terry; N D Arnold; D R Siemieniak; R J Kaufman; D Ginsburg
Journal:  J Clin Invest       Date:  1997-02-15       Impact factor: 14.808

2.  Molecular basis of thrombin recognition by protein C inhibitor revealed by the 1.6-A structure of the heparin-bridged complex.

Authors:  Wei Li; Ty E Adams; Jyoti Nangalia; Charles T Esmon; James A Huntington
Journal:  Proc Natl Acad Sci U S A       Date:  2008-03-24       Impact factor: 11.205

3.  Anticoagulant synergism of heparin and activated protein C in vitro. Role of a novel anticoagulant mechanism of heparin, enhancement of inactivation of factor V by activated protein C.

Authors:  J Petäjä; J A Fernández; A Gruber; J H Griffin
Journal:  J Clin Invest       Date:  1997-06-01       Impact factor: 14.808

Review 4.  Combined factors V and VIII deficiency climbs onto the map.

Authors:  J E Sadler
Journal:  J Clin Invest       Date:  1997-02-15       Impact factor: 14.808

5.  The locus for combined factor V-factor VIII deficiency (F5F8D) maps to 18q21, between D18S849 and D18S1103.

Authors:  M Neerman-Arbez; S E Antonarakis; J L Blouin; S Zeinali; M Akhtari; Y Afshar; E G Tuddenham
Journal:  Am J Hum Genet       Date:  1997-07       Impact factor: 11.025

6.  Inhibition of activated protein C by platelets.

Authors:  S M Jane; C A Mitchell; L Hau; H H Salem
Journal:  J Clin Invest       Date:  1989-01       Impact factor: 14.808

7.  Expression patterns of protein C inhibitor in mouse development.

Authors:  Gerry T M Wagenaar; Pavel Uhrin; Klara Weipoltshammer; Marlene Almeder; Pieter S Hiemstra; Margarethe Geiger; Joost C M Meijers; Christian Schöfer
Journal:  J Mol Histol       Date:  2010-03-14       Impact factor: 2.611

8.  Evidence of normal functional levels of activated protein C inhibitor in combined Factor V/VIII deficiency disease.

Authors:  W M Canfield; W Kisiel
Journal:  J Clin Invest       Date:  1982-12       Impact factor: 14.808

9.  Additional factor XII (Hageman factor) deficiency in hemophilia A and in von Willebrand syndrome.

Authors:  M Barthels; J Edel; B Liese; H E Karges
Journal:  Klin Wochenschr       Date:  1982-03

10.  Detection of a new heparin-dependent inhibitor of thrombin in human plasma.

Authors:  D M Tollefsen; M K Blank
Journal:  J Clin Invest       Date:  1981-09       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.